Desire Collen

Publication List Details

Period

1991 - 2005

Number

37

Co-Authors

Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction (2004)

Janssens, S, Schoonjans, Luc; U0009528, Pellens, Marijke; U0033117, Vermeersch, Pieter; U0035259, Tjwa, Marc; U0034792, ...

Nitric oxide ( NO) is an important modulator of cardiac performance and left ventricular (LV) remodeling after myocardial infarction (MI). We tested the effect of cardiomyocyte-restricted...

Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis (2002)

Sinnaeve, Peter; U0011642, Chiche, Jean-Daniel, Gillijns, Hilde, Van Pelt, Natascha, Wirthlin, Douglas, Van De Werf, Frans; U0009589, ...

BACKGROUND: Neointima formation after arterial injury is associated with reduced vascular cyclic guanosine monophosphate (cGMP) and cGMP-dependent protein kinase (PKG), a major cGMP effector in...

Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats (2000)

Budts, Werner; U0037749, Nong, ZX, Van Pelt, N, Gillijns, H, Gerard, R, ...

BACKGROUND: Nitric oxide (NO) is a potent vasodilator with an important role in the regulation of pulmonary vascular tone. The effects of NO synthase (NOS) gene transfer on pulmonary vascular...

Characterization of a helicase-like transcription factor involved in the expression of the human plasminogen activator inhibitor-1 gene (1996)

Ding, H, Descheemaeker, K, Marynen, Peter; U0008800, Nelles, Lucien; U0019373, Carvalho, T, Carmo-Fonseca, M, ...

A 5.4-kb cDNA encoding the protein that binds to the B Box of the plasminogen activator inhibitor-1 (PAI-1) gene was isolated and sequenced. The protein, named helicase-like transcription factor...

Pilot-study of combined administration of ridogrel and alteplase in patients with acute myocardial-infarction (1991)

Rapold, Hj, Van De Werf, Frans; U0009589, Degeest, H, Arnout, Jozef; U0003986, Sangtawesin, W, Vercammen, E, ...

The feasibility and pharmacodynamics of combined treatment with ridogrel, a thromboxane A2 synthase inhibitor and prostaglandin endoperoxide receptor antagonist, and alteplase (recombinant...